• Amendments to the E-mini Nasdaq Biotechnology Index Futures Contract

      • #
      • MSN08-11-21
      • Notice Date
      • 11 August 2021
      • Effective Date
      • 16 August 2021

    • In connection with the amendments to the Chicago Mercantile Exchange Inc. (“CME”) E-mini Nasdaq Biotechnology Index Futures Contract (the “contract”) on trade date Monday August 16, 2021 (see SER-8794R published on August 2, 2021), please note below and in Exhibit C of CME Submission No. 21-216 the corresponding all-month position limit (Rule 559), aggregation allocations (Rule 559.D) and reportable level (Rule 561) for the contract.

      For the full text of this notice, please see link attached below.

      Amendments to the E-mini Nasdaq Biotechnology Index Futures Contract

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2026 CME Group Inc. All rights reserved.